贵圈
政府都对党
- 注册
- 2014-10-21
- 消息
- 32,808
- 荣誉分数
- 6,137
- 声望点数
- 373
My View
Following
Saved
1 minute readFebruary 1, 20234:30 PM ESTLast Updated 2 days ago
U.S. FDA removes COVID test requirements for Pfizer, Merck pills
Reuters
Illustration shows Pfizer logo
[1/2] Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration
Companies
Pfizer Inc
Merck & Co Inc
U.S. Food and Drug Administration
Feb 1 (Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday removed the need for a positive test for COVID-19 treatments from Pfizer Inc (PFE.N) and Merck & Co Inc (MRK.N).
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021 for patients with mild-to-moderate COVID who tested positive for the virus, and who were at risk of progressing to severe COVID.
Following
Saved
1 minute readFebruary 1, 20234:30 PM ESTLast Updated 2 days ago
U.S. FDA removes COVID test requirements for Pfizer, Merck pills
Reuters
Illustration shows Pfizer logo
[1/2] Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration
Companies
Pfizer Inc
Merck & Co Inc
U.S. Food and Drug Administration
Feb 1 (Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday removed the need for a positive test for COVID-19 treatments from Pfizer Inc (PFE.N) and Merck & Co Inc (MRK.N).
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021 for patients with mild-to-moderate COVID who tested positive for the virus, and who were at risk of progressing to severe COVID.
